HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$27.34
Day range
$26.76 - $28.00
Year range
$14.42 - $38.93
Market cap
754.60M USD
Avg Volume
284.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.93M | 5.24% |
Net income | -14.62M | 12.19% |
Net profit margin | — | — |
Earnings per share | -0.53 | — |
EBITDA | -16.90M | -5.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 193.98M | -9.05% |
Total assets | 201.25M | -7.39% |
Total liabilities | 9.24M | -51.75% |
Total equity | 192.01M | — |
Shares outstanding | 28.15M | — |
Price to book | 3.92 | — |
Return on assets | -20.32% | — |
Return on capital | -21.23% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -14.62M | 12.19% |
Cash from operations | -16.05M | 32.95% |
Cash from investing | 18.89M | 4.94% |
Cash from financing | 44.00K | -99.97% |
Net change in cash | 2.88M | -98.26% |
Free cash flow | -10.88M | 0.86% |
About
Founded
2013
Headquarters
Website
Employees
42
